The tuberous sclerosis complex regulates trafficking of glucose transporters and glucose uptake
about
The sweet trap in tumors: aerobic glycolysis and potential targets for therapyTherapeutic targeting of cellular metabolism in cells with hyperactive mTORC1: a paradigm shiftAppetite for destruction: the inhibition of glycolysis as a therapy for tuberous sclerosis complex-related tumorsTuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transitionThe last enzyme of the de novo purine synthesis pathway 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC) plays a central role in insulin signaling and the Golgi/endosomes protein networkActivation of a metabolic gene regulatory network downstream of mTOR complex 1mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway.Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.T-cell and B-cell signaling biomarkers and treatment targets in lupus.Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells.Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradationClinically relevant imaging in tuberous sclerosis.Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosis.Glucose deprivation in tuberous sclerosis complex-related tumors.Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2.NOX4 pathway as a source of selective insulin resistance and responsivenessLymphangioleiomyomatosis - a wolf in sheep's clothing.FDG PET or PET/CT in evaluation of renal angiomyolipomaPI3K/mTORC1 activation in hamartoma syndromes: therapeutic prospects.Insulin receptor substrate-2 regulates aerobic glycolysis in mouse mammary tumor cells via glucose transporter 1.mTOR in renal cell cancer: modulator of tumor biology and therapeutic target.Potential role of sugar transporters in cancer and their relationship with anticancer therapy.Tumor glycolysis as a target for cancer therapy: progress and prospects.The CLASP2 Protein Interaction Network in Adipocytes Links CLIP2 to AGAP3, CLASP2 to G2L1, MARK2, and SOGA1, and Identifies SOGA1 as a Microtubule-Associated Protein.Characterization and modulation of glucose uptake in a human blood-brain barrier model.mTOR is involved in stroke-induced seizures and the anti-seizure effect of mild hypothermia.Tuberous sclerosis complex renal disease.
P2860
0c38e70d184d913020801318a89a8ce098c6969a29257793825316e72905063cec4d9aec980ea5dc410b01d9382e1e0af27f81c9bc664b6775fb204648013e667fc58d1f6c1281a06cde0b667d3a2a3b8f85cb3151a6d453d1421056317c75115ee9d21c93d7a731e5929984b52b4ef65d8323f3249fbf899b20e7bda83edc2549005a9809e37a3eb80c8a0bd522c874baf0e53fd858c40cfc0b8cc2a02989a8
P248
Q26766079-57365E04-95ED-4BFB-A805-C9B5F926732FQ26999365-2D3F7BFD-021E-4FF8-A275-B5F3B1A7BEE1Q27015394-4F6F2D34-499C-4894-BC87-012C66EA4D11Q28566030-F705DA44-3002-4F49-A47B-D76453AB426EQ28573050-5871EC46-EC5D-4F0D-8151-4D6A3409E8AEQ29615179-998B7968-065C-485F-8BD9-8794AD51E8A9Q30425628-0F964A58-B7C3-4454-903D-A94CC9C85C2CQ33608479-CC1F40D1-11D1-4211-9A6E-291C5CDABEE2Q33718893-2986130F-37C9-4417-983E-409E4654C347Q33720145-28FBB7CB-4A98-427D-9449-F961B33A4077Q34939946-1DDADF97-6B74-45BE-9A10-28118A2C6DA7Q35224736-7BA82819-9B13-49BC-B8BC-D5B0FA47655CQ35410898-0F991EDD-0C41-4D21-A5EC-8DCFABB15901Q35560024-4C572765-4547-4DB1-96A6-5990B7FAEF0BQ36041589-131372D4-4841-4329-9172-54D4CC84EC50Q36099612-F9DD5036-AE26-4B42-9B05-A73B7AF9C22EQ36357766-CAEF3844-6CA2-4BEA-AC76-2700BCC3D18FQ36662636-5F563FE3-8826-4E37-8532-7B4CDBA80794Q37032524-33128FDA-B38A-4B47-A9A2-8DB91E05A924Q37068060-A6B89C2D-CFBC-4B48-A143-55933BF74306Q37451552-086D90F3-183B-406C-AA46-5C90253FB63DQ37779733-64D49F77-147E-45FB-A0CB-86ABC6D9F74DQ38168262-0C18AD11-2256-4ECC-B5C4-D135C6FA8B36Q38760699-E50D5FA8-91C8-4D1B-94F2-DBBE72EA8476Q39105383-FDB14F39-A7F4-4279-AED0-875F9508C023Q52684047-D7653ED4-E262-4D4F-9BE4-521683EBD14BQ55480104-95AEF0D0-CBAC-479C-9204-267886912B8D
P2860
The tuberous sclerosis complex regulates trafficking of glucose transporters and glucose uptake
description
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im Juni 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/06/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/06/01)
@nl
наукова стаття, опублікована в червні 2008
@uk
مقالة علمية (نشرت في يونيو 2008)
@ar
name
The tuberous sclerosis complex ...... ransporters and glucose uptake
@ast
The tuberous sclerosis complex ...... ransporters and glucose uptake
@en
The tuberous sclerosis complex ...... ransporters and glucose uptake
@nl
type
label
The tuberous sclerosis complex ...... ransporters and glucose uptake
@ast
The tuberous sclerosis complex ...... ransporters and glucose uptake
@en
The tuberous sclerosis complex ...... ransporters and glucose uptake
@nl
prefLabel
The tuberous sclerosis complex ...... ransporters and glucose uptake
@ast
The tuberous sclerosis complex ...... ransporters and glucose uptake
@en
The tuberous sclerosis complex ...... ransporters and glucose uptake
@nl
P2093
P2860
P921
P1476
The tuberous sclerosis complex ...... ransporters and glucose uptake
@en
P2093
Heidi Kenerson
Janet Eary
Lauri Aicher
Raymond S Yeung
Robert Miyaoka
Xiuyun Jiang
P2860
P304
P356
10.2353/AJPATH.2008.070958
P407
P577
2008-06-01T00:00:00Z